Atrial fibrillation, stroke, and quality of life

Area of Science:

• Cardiology
• Geriatrics
• Neurology

Background:

• Atrial fibrillation management is complex, especially in aging populations.
• Emerging evidence links atrial fibrillation to increased dementia risk.
• Balancing stroke prevention and anticoagulation-related bleeding is critical in elderly patients.

Purpose of the Study:

• To review contemporary challenges and evolving strategies in atrial fibrillation management.
• To discuss novel antithrombotics, mechanical alternatives, and catheter ablation for stroke prevention.
• To address the complexities of managing bleeding risks in patients requiring multiple antithrombotic therapies.

Main Methods:

• Review of current literature and practice guidelines on atrial fibrillation management.
• Analysis of emerging evidence on stroke, dementia, and bleeding risks.
• Evaluation of novel antithrombotic agents and interventional procedures.

Main Results:

• Novel antithrombotics and mechanical devices offer effective stroke prevention with potentially lower bleeding risk.
• Catheter ablation shows promise in reducing atrial fibrillation recurrence and improving outcomes.
• Identifying patients at low thromboembolic risk and high bleeding risk is crucial for tailored management.
• High bleeding risks remain a significant challenge with combined antiplatelet and anticoagulant therapy.

Conclusions:

• Contemporary atrial fibrillation management requires careful risk stratification and consideration of novel therapeutic options.
• Individualized treatment strategies are essential to optimize stroke prevention while minimizing bleeding complications.
• Further research is needed for novel agents and managing complex antithrombotic regimens.